Reporters.io
Alexandra Pecci
Pharma Voice
Profile
Contacts
Recent Articles on Subject
1
Alexandra Pecci
Pharma Voice
Leading community for life sciences leaders.
Washington, D.C.
pharmaceuticals
life sciences
community building
How a 15-year-old Genzyme drug shortage became a legal smorgasbord of pharma’s thorniest issues
- 9 months ago
Ferring’s microbiome and gene therapy firsts take the company beyond reproductive health
- 9 months ago
4 biotechs to watch in 2024
- 9 months ago
‘Hey, AI: Is Zoloft effective for me?’ Tech’s foray into predictive prescribing
- 9 months ago
Why a former BMS exec calls her new CEO role ‘unfinished business’ in cancer care
- 9 months ago
Government hits patent thickets on multiple fronts
- 9 months ago
FDA looks to execute ‘largest reorganization in history’ this year
- 10 months ago
The hunt for an elusive universal coronavirus vaccine
- 10 months ago
An enduring COVID mystery: Why some do fine and others die
- 10 months ago
FDA chief says agency can’t manage health tech alone
- 10 months ago
Why J&J rebranded its iconic logo
- 11 months ago
5 noteworthy pharma AI investments in 2023
- 11 months ago
Rise of the chief investment officer: Why the unique role works for Roivant
- 11 months ago
Study suggests PBMs are gaming pharmacy system to overcharge for drugs
- 11 months ago
Patients who hide pills and advocacy offices that could get ‘raided’ — a Gilead leader on navigating global HIV
- 11 months ago
4 historic FDA approvals from 2023
- 11 months ago
The fortunes and flops of pharma M&A
- 12 months ago
Biopharma’s top 5 IPOs of 2023 (so far)
- 12 months ago
How EMD Serono plans to hit its lofty goals in R&D
- 12 months ago
The biopharma COO’s playbook
- 12 months ago
The power of genomics-based healthcare remains largely untapped
- 12 months ago
6 ways to improve clinical trial diversity — as shown by J&J
- about 1 year ago
5 of the best paid biopharma CEOs
- about 1 year ago
23andMe CEO Anne Wojcicki’s vision for changing healthcare as a ‘full-fledged biotech’
- about 1 year ago
In a record year for biotech bankruptcy, here are 3 companies that went under
- about 1 year ago
Wisp’s ‘bold and unapologetic approach’ to women’s sexual and reproductive health
- about 1 year ago
Red Jacket: Ken Getz, a champion of clinical trials
- about 1 year ago
Red Jacket: Dr. Mark Goldberg, a clinical innovator
- about 1 year ago
Cidara’s J&J-partnered immunotherapy could target flu and cancer
- about 1 year ago
For women’s health, Organon changed the financial language
- about 1 year ago
The FDA might yank cold medicines from shelves — and that could be just the beginning
- about 1 year ago
To close the pediatric innovation gap, this biotech has to think differently
- about 1 year ago
Where have all the unicorns gone? A look at 4 billion-dollar biotechs
- about 1 year ago
What happened to ivermectin?
- about 1 year ago